The role of interleukin-17 in neurological disorders
Open Access
- 3 June 2025
- journal article
- review article
- Published by Taylor & Francis in Animal Cells and Systems
- Vol. 29 (1) , 372-386
Abstract
In recent years, the intricate relationship between the immune system and neurological disorders has garnered significant attention. While the central nervous system had long been perceived as immunologically privileged, emerging research has revealed complex interactions among immune cells, inflammatory mediators, and neural components that collectively influence the pathogenesis and progression of various neurological disorders. This comprehensive review explores the crucial role of the cytokine interleukin-17(IL-17) in neurological diseases. It examines the complex contributions of IL-17 to both neurodevelopmental and neurodegenerative disorders, highlighting its diverse mechanisms and its impact on neuro-immune crosstalk. Moreover, we assess the evidence supporting the potential therapeutic role of modulating IL-17, considering its beneficial and detrimental effects. Through a comprehensive analysis of current research, we aim to provide insights into the modulatory role of IL-17 in neurological disorders.Keywords
Funding Information
- National Research Foundation of Korea
- Korean government (RS-2024-00352560)
- São Paulo State Research Foundation (2022/14820-9)
- National Council for Scientific and Technological Development
- CNPq (306077/2023-0)
- FAPESP (2018/07366-4)
- CNPq (440993/2023-7)
- The NRF (RS-2023-00209464, RS-2023-00302229, RS-2024-00467876, RS-2024-00399013)
- Technology Innovation Program (20023378)
- Ministry of Trade, Industry & Energy
- Korea University (K2225821)
This publication has 142 references indexed in Scilit:
- Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineagesNature Immunology, 2005
- IL-23 drives a pathogenic T cell population that induces autoimmune inflammationJournal of Experimental Medicine, 2005
- The STIR-domain superfamily in signal transduction, development and immunityTrends in Biochemical Sciences, 2003
- Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitisNature Medicine, 2002
- IL‐17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL‐17F, and implications for receptor bindingThe EMBO Journal, 2001
- A pathogenic role for γ δ T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouseThe Journal of Immunology, 1996
- Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptorImmunity, 1995
- γδ+ T cells are increased in patients with Parkinson's diseaseJournal of the Neurological Sciences, 1994
- CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri geneThe Journal of Immunology, 1993
- Peripheral blood γ‐δ T cells lyse fresh human brain—Derived oligodendrocytesAnnals of Neurology, 1991